Hypertension is the most common modifiable risk factor for cardiovascular disease and
death, and lowering blood pressure with antihypertensive drugs reduces target organ …

Executive summary Elevated blood pressure is the strongest modifiable risk factor for
cardiovascular disease worldwide. Despite extensive knowledge about ways to prevent as …

Arterial hypertension is the most prevalent modifiable risk factor associated with
cardiovascular morbidity and mortality. Although antihypertensive drugs are widely …

The prevalence of obesity has tripled over the past five decades. Obesity, especially visceral
obesity, is closely related to hypertension, increasing the risk of primary (essential) …

Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

Objectives: The objective of this clinical trial was to assess the safety and efficacy of carotid
BAT in advanced HF. Background: Increased sympathetic and decreased parasympathetic …

The regulatory landscape for device-based heart failure (HF) therapies has seen a major
shift in the last 7 years. In 2013, the US Food and Drug Administration released guidance for …

An ablation catheter comprises a catheter body extending longitudinally between a proximal
end and a distal end along a longitudinal axis; and an ablation element assembly com …

Heart failure affects over 2.6 million women and 3.4 million men in the United States with
known sex differences in epidemiology, management, response to treatment, and outcomes …

PAD: presión arterial diastólica PAS: presión arterial sistólica PPAR: receptores activadores
de la proliferación peroxisomal PWV: velocidad de la onda de pulso RAA: renina …